Development and implementation of a performance improvement project in adult intensive care units: Overview of the Improving Medicine Through Pathway Assessment of Critical Therapy in Hospital-Acquired Pneumonia (IMPACT-HAP) study

Critical Care

Volumn 15, Issue 1, 2011, Pages

  Mangino, Julie E ^a   Peyrani, Paula ^b   Ford, Kimbal D ^c   Kett, Daniel H ^d   Zervos, Marcus J ^e   Welch, Verna L ^c   Scerpella, Ernesto G ^c   Ramirez, Julio A ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

^c PFIZER INC   (United States)

^d JACKSON MEMORIAL HOSPITAL   (United States)

^e WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; FEMALE; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; UNITED STATES; VENTILATOR ASSOCIATED PNEUMONIA; CLINICAL TRIAL; CROSS INFECTION; FEASIBILITY STUDY; HEALTH CARE QUALITY; INTENSIVE CARE UNIT; MIDDLE AGED; MULTICENTER STUDY; ORGANIZATION AND MANAGEMENT; STANDARD; TOTAL QUALITY MANAGEMENT; UNIVERSITY HOSPITAL;

ACADEMIC MEDICAL CENTERS; ADULT; AGED; CRITICAL CARE; CROSS INFECTION; FEASIBILITY STUDIES; FEMALE; GUIDELINE ADHERENCE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PNEUMONIA, VENTILATOR-ASSOCIATED; PRACTICE GUIDELINES AS TOPIC; QUALITY IMPROVEMENT; QUALITY INDICATORS, HEALTH CARE; UNITED STATES;

EID: 79952315234     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc9988     Document Type: Article

References (27)

1. American Thoracic Society and the Infectious Diseases Society of America Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005, 171:388-416. 10.1164/rccm.200405-644ST, 15699079, American Thoracic Society and the Infectious Diseases Society of America.
2. Mangino JE, Ford KD, Peyrani P, Kett DH, Zervos MJ, Scerpella E, Ramirez JA. Implementing national guidelines to improve outcomes in patients with hospital-acquired pneumonia: the IMPACT HAP Project. ASHP 42nd Midyear Clinical Meeting; Las Vegas, Nevada 2007,
3. Mangino JE, Ramirez JA, Peyrani P, Kett DH, Zervos MJ, Ford KD, Scerpella EG, . the IMPACT-HAP Study Group Development of quality indicators to measure adherence to guidelines in intensive care patients with ventilator-associated, hospital-acquired and healthcare associated pneumonia: the IMPACT-HAP Project (abstract). 18th Annual Scientific Meeting of The Society for Healthcare Epidemiology of America (SHEA) 2008, Orlando, Florida, the IMPACT-HAP Study Group.
4. Mangino JE, Peyrani P, Kett DH, Zervos MJ, Scerpella EG, Ford KD, Ramirez JA. Use of quality indicators to measure compliance with the ATS/IDSA Guidelines for hospital-acquired pneumonia (HAP), healthcare-associated pneumonia (HCAP) and ventilator-associated pneumonia (VAP) at 4 medical centers: the IMPACT-HAP Project (abstract). 48th Annual ICAAC/IDSA 46th Annual Meeting 2008, Washington, DC.
5. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008, 36:309-332. 10.1016/j.ajic.2008.03.002, 18538699.
6. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101:1644-1655. 10.1378/chest.101.6.1644, 1303622.
7. Singh N, Rogers P, Atwood CW, Wagener MM, Yu VL. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med 2000, 162:505-511.
8. Dobesh PP, Bosso J, Wortman S, Dager WE, Karpiuk EL, Ma Q, Zarowitz BJ. Critical pathways: the role of pharmacy today and tomorrow. Pharmacotherapy 2006, 26:1358-1368. 10.1592/phco.26.9.1358, 16945060.
9. Kollef M. SMART approaches for reducing nosocomial infections in the ICU. Chest 2008, 134:447-456. 10.1378/chest.08-0809, 18682466.
10. Craven DE. Preventing ventilator-associated pneumonia in adults: sowing seeds of change. Chest 2006, 130:251-260. 10.1378/chest.130.1.251, 16840410.
11. Brito V, Niederman MS. Standardized care for nosocomial pneumonia is a valuable tool to improve patient outcomes: how do we get intensivists to listen?. Crit Care Med 2009, 37:350-352. 10.1097/CCM.0b013e3181931108, 19112300.
12. Soo Hoo GW, Wen YE, Nguyen TV, Goetz MB. Impact of clinical guidelines in the management of severe hospital-acquired pneumonia. Chest 2005, 128:2778-2787. 10.1378/chest.128.4.2778, 16236955.
13. Ibrahim EH, Ward S, Sherman G, Schaiff R, Fraser VJ, Kollef MH. Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Crit Care Med 2001, 29:1109-1115. 10.1097/00003246-200106000-00003, 11395584.
14. Micek ST, Ward S, Fraser VJ, Kollef MH. A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator-associated pneumonia. Chest 2004, 125:1791-1799. 10.1378/chest.125.5.1791, 15136392.
15. Babcock HM, Zack JE, Garrison T, Trovillion E, Jones M, Fraser VJ, Kollef MH. An educational intervention to reduce ventilator-associated pneumonia in an integrated health system: a comparison of effects. Chest 2004, 125:2224-2231. 10.1378/chest.125.6.2224, 15189945.
16. Zack JE, Garrison T, Trovillion E, Clinkscale D, Coopersmith CM, Fraser VJ, Kollef MH. Effect of an education program aimed at reducing the occurrence of ventilator-associated pneumonia. Crit Care Med 2002, 30:2407-2412. 10.1097/00003246-200211000-00001, 12441746.
17. Beardsley JR, Williamson JC, Johnson JW, Ohl CA, Karchmer TB, Bowton DL. Using local microbiologic data to develop institution-specific guidelines for the treatment of hospital-acquired pneumonia. Chest 2006, 130:787-793. 10.1378/chest.130.3.787, 16963676.
18. Seymann GB, Di Francesco L, Sharpe B, Rohde J, Fedullo P, Schneir A, Fee C, Chan KM, Fatehi P, Dam TT. The HCAP gap: differences between self-reported practice patterns and published guidelines for health care-associated pneumonia. Clin Infect Dis 2009, 49:1868-1874. 10.1086/648429, 19911940.
19. Dellit TH, Chan JD, Skerrett SJ, Nathens AB. Development of a guideline for the management of ventilator-associated pneumonia based on local microbiologic findings and impact of the guideline on antimicrobial use practices. Infect Control Hosp Epidemiol 2008, 29:525-533. 10.1086/588160, 18510462.
20. Ferrer M, Liapikou A, Valencia M, Esperatti M, Theessen A, Antonio Martinez J, Mensa J, Torres A. Validation of the American Thoracic Society-Infectious Diseases Society of America guidelines for hospital-acquired pneumonia in the intensive care unit. Clin Infect Dis 2010, 50:945-952. 10.1086/651075, 20175690.
21. Miletin MS, Chan CK. The use of guidelines for the empirical treatment of hospital-acquired pneumonia. Can Respir J 2001, 8:255-260.
22. Nachtigall I, Tamarkin A, Tafelski S, Deja M, Halle E, Gastmeier P, Wernecke KD, Bauer T, Kastrup M, Spies C. Impact of adherence to standard operating procedures for pneumonia on outcome of intensive care unit patients. Crit Care Med 2009, 37:159-166. 10.1097/CCM.0b013e3181934f1b, 19050600.
23. American Thoracic Society Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. A consensus statement, American Thoracic Society, November 1995. Am J Respir Crit Care Med 1996, 153:1711-1725. American Thoracic Society.
24. Venditti M, Falcone M, Corrao S, Licata G, Serra P. Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia. Ann Intern Med 2009, 150:19-26.
25. Kett DH, Cano E, Quartin AA, Mangino JE, Zervos MJ, Peyrani P, Cely CM, Ford KD, Scerpella EG, Ramirez JA. Implementation of guidelines for management of possible multidrug-resistant pneumonia in intensive care: an observational, multicentre cohort study. Lancet ID 2011,
26. Mirsaeidi M, Peyrani P, Ramirez JA. Predicting mortality in patients with ventilator-associated pneumonia: The APACHE II score versus the new IBMP-10 score. Clin Infect Dis 2009, 49:72-77. 10.1086/599349, 19480582.
27. Haque NZ, Cahuayme Zuniga L, Peyrani P, Reyes K, Lamerato L, Moore CL, Patel S, Allen M, Peterson E, Wiemken T, Cano E, Mangino JE, Kett DH, Ramirez JA, Zervos MJ, . the Improving Medicine through Pathway Assessment of Critical Therapy of Hospital-Acquired Pneumonia (IMPACT-HAP) Investigators Relationship of vancomycin MIC to mortality in patients with methicillin-resistant Staphylococcus aureus hospital-acquired, ventilator-associated or healthcare-associated pneumonia. Chest 2010, 138(6):1356-1362. 10.1378/chest.09-2453, 20558550, the Improving Medicine through Pathway Assessment of Critical Therapy of Hospital-Acquired Pneumonia (IMPACT-HAP) Investigators.